Nike's stock sees a 24% dip amid tariff challenges and weak Q4 metrics. Click here to read an analysis of NKE stock now.

Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...

Affirm Holdings is a top investment pick with 2,335% profit growth by 2026, driven by BNPL market expansion and improving ...

Microchip Technology's 2024 struggles with high inventory, debt, and economic challenges make it a risky investment. Read why ...

Silver, while volatile and heavily used in industry, serves as a proxy for gold, especially during fear trades. Expert Don ...

RBC cuts its 2025 S&P target by 11% to 5,550, seeing a growth scare rising amid Trump tariffs. Read more here.

The yardstick of fear among investors, the CBOE Volatility Index, surged past 28 on Thursday, well above its 10-year average.

Recession odds are rising. Read more on the long-term market reaction and what investors are doing to prepare for volatile times.

Shares 20+ Year Treasury Bond ETF benefits from tariff impacts and lower growth expectations. Find out why I have a buy ...

Invest smartly with dividend growth stocks! Learn how consistent dividend increases and solid financial health build ...

Sky Harbour Group's long-term growth potential justifies a speculative buy, with a price target of $22.28 once revenue goals ...

Imperial Brands' dividend yield dropped from 11% to 5.5%, making it less attractive amid rising bond yields. Read why IMBBF ...